In the patients with autoimmune/autoinflammatory diseases described in this review, co-morbidities such as metabolic syndrome and diabetes are often present
the FTCs February 2026 Express Scripts settlement has introduced new constraints on rebate retention structures
A study at Penn Medicine, funded by Novo Nordisk, found that participants taking semaglutide lost an average of 16% of their starting weight and more than one-third lost 20% or more of their baseline weight during the 68-week study
In aesthetic medicine, balance matters more than trends
Follicles are mini-organs with their own immune environment, stem cell populations, vascular supply, and hormonal sensitivity. That scientific complexity has long constrained progress
This medication was first created for type 2 diabetes but can be used for weight loss as well